Venous Thromboembolism
VENOUS THROMBOEMBOLISM
... Venous thromboembolism is a blood clot that starts inside a vein. Venous thromboembolism (VTE) is a major health and financial burden that affects the ...of venous ...
7
Cardiovascular risk factors associated with venous thromboembolism
... Cardiovascular Risk Factors Associated With Venous Thromboembolism Institute for Health and Welfare, Helsinki, Finland Salomaa; Ludwig Maximilian University of Munich, Munich, Germany Me[r] ...
11
Venous Thromboembolism Diagnosis and Treatment
... ICSI Venous Thromboembolism Diagnosis and Treatment guideline was developed to assist clinicians and institutions with an evidence-based approach to the diagnosis and acute management of the majority of ...
91
New anticoagulants for the prevention of venous thromboembolism
... The majority of new anticoagulants currently under investigation are small molecules with a selective and direct anti-Xa or antithrombin action, allowing oral administration in fixed doses. These new agents are in ...
12
Direct oral anticoagulants and venous thromboembolism
... Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE), is a major cause of morbidity and mortality worldwide, occurring in approximately one in 1000 adults ...
8
Prevention, diagnosis and treatment of venous thromboembolism
... Venous thromboembolism (VTE) is caused by a blood clot in a vein, usually the lower limb, which causes blood to stop in ...a venous vessel, ...developing venous thromboembolism ...
7
The effects of obesity on venous thromboembolism: A review
... Obesity has emerged as a global health issue that is associated with wide spectrum of dis- orders, including coronary artery disease, dia- betes mellitus, hypertension, stroke, and venous thromboembolism ...
11
The role of dyslipidemia and statins in venous thromboembolism
... the past 20 years is sure to contain a lengthy discussion of the role of dyslipidemia in the development of both athero- sclerosis and acute arterial thrombosis [1]. Elevated total serum cholesterol, elevated ...
6
D-dimer for Exclusion of Venous Thromboembolism
... D-dimer testing for DVT/PE exclusion is particularly useful considering the prevalence of the disease among clinically suspected outpatients. This has been decreasing steadily over the past fifteen years with reported ...
26
Venous thromboembolism in head and neck cancer surgery
... Venous thromboembolism is a major source of peri- operative morbidity and mortality that is largely pre- ventable. It accounts for approximately 10 % of hospital deaths annually [3], and patients that ...
8
Edoxaban in venous thromboembolism and stroke prevention: an appraisal
... Abstract: Oral anticoagulation is the therapeutic cornerstone in preventing thromboembolic risk in both atrial fibrillation (AF) and venous thromboembolism (VTE). After decades of the sole therapeutic oral ...
7
Feasibility and safety of rehabilitation after venous thromboembolism
... recurrent venous thromboembolism (VTE), severe bleedings, or deaths were not found; and 2) the suggested standard rehabilitation program including intensive sports therapy was ...
5
New anticoagulants for the prevention and treatment of venous thromboembolism
... Venous thromboembolism (VTE), consisting of deep vein thrombosis (DVT) and pulmonary embolism (PE), is a common and potentially fatal disease with an annual incidence of ...of venous thrombosis is ...
13
The diagnosis and treatment of venous thromboembolism in Asian patients
... for Venous Thromboembolism in the Acute Hospital Care Setting; INR: International normalized ratio; JCS: Japanese Circulation Society; LMWH: Low-molecular-weight heparin; NOAC: Non-vitamin K antagonist oral ...
12
Air travel and venous thromboembolism: Minimizing the risk
... The absolute risk of venous thromboembolism (VTE) is low. This tool has been devised in an effort to help guide the clinician in making a decision about when to use low-molecular-weight heparin or an ...
10
Family history of venous thromboembolism is a risk factor for venous thromboembolism in combined oral contraceptive users: a nationwide case-control study
... The dataset for these analyses was created by identifying from the Swedish Hospital Discharge Register and the Outpatient Care Register all females aged 15-49 with diag- noses of VTE during the period 2006 to 2010. We ...
8
Safety of apixaban for venous thromboembolism prophylaxis: the evidence to date
... of venous thromboembolism (VTE) in patients undergoing elective total-hip or total-knee arthroplasty, for acute treatment/prevention of recurrent events in patients with VTE, and extended prophylaxis in ...
14
Review Venous Thromboembolism Risk with Anti Osteoporosis Drugs
... However, the risk of developing venous thromboembolism (VTE) is increased two to four times in women using oral THM. Due to their hepatic effect, there is an increase in the production of pro-inflammatory ...
9
Pathways for outpatient management of venous thromboembolism in a UK centre.
... CTEPH: Chronic thromboembolic pulmonary hypertension; CTPA: Computed tomography pulmonary angiogram; DVT: Deep vein thrombosis; HAS- BLED: Hypertension Abnormal renal and liver function, Stroke, Bleeding, Labile ...
8
Contraception and Venous Thromboembolism: Risk Factors and Clinical Considerations
... of venous thromboembolism (VTE) is a known risk with some forms of hormonal contraception and this is an important consideration when health care providers (HCPs) counsel patients about contraceptive ...
15